Evidence map›Paper›PMID 42112451›Full record

ArticleFrontiers in microbiology2026

Culture, qPCR, and genome-based surveillance of

Andrés Cortez-Astorga, Diego Lira-Velásquez, Richard Covarrubia-López, Juan Castro-Severyn, Gabriel I Krüger, Nicolás Pacheco, Aldo Gaggero, Francisco Remonsellez, Sofía Quintana, Felipe Vásquez-Ponce and 2 more

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andrés Cortez-AstorgaGrupo de Resistencia Antimicrobiana en Bacterias Patógenas y Ambientales (GRABPA), Instituto de Biología, Pontificia Universidad Católica de Valparaíso, Valparaiso, Chile.
Diego Lira-VelásquezGrupo de Resistencia Antimicrobiana en Bacterias Patógenas y Ambientales (GRABPA), Instituto de Biología, Pontificia Universidad Católica de Valparaíso, Valparaiso, Chile.
Richard Covarrubia-LópezGrupo de Resistencia Antimicrobiana en Bacterias Patógenas y Ambientales (GRABPA), Instituto de Biología, Pontificia Universidad Católica de Valparaíso, Valparaiso, Chile.
Juan Castro-SeverynLaboratorio de Microbiología Molecular, One Health Institute, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago, Chile.
Gabriel I KrügerFacultad de Ingeniería y Negocios, Universidad de las Américas, Providencia, Santiago, Chile.
Nicolás PachecoLaboratorio de Microbiología Molecular, One Health Institute, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago, Chile.
Aldo GaggeroPrograma de Virología, ICBM, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Francisco RemonsellezLaboratorio de Microbiología Aplicada y Extremófilos, Departamento de Ingeniería Química, Universidad Católica del Norte, Antofagasta, Chile.
Sofía QuintanaLaboratorio de Microbiología Molecular, One Health Institute, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago, Chile.
Felipe Vásquez-PonceGrupo de Resistencia Antimicrobiana en Bacterias Patógenas y Ambientales (GRABPA), Instituto de Biología, Pontificia Universidad Católica de Valparaíso, Valparaiso, Chile.
Claudia P SaavedraLaboratorio de Microbiología Molecular, One Health Institute, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago, Chile.
Jorge Olivares-PachecoGrupo de Resistencia Antimicrobiana en Bacterias Patógenas y Ambientales (GRABPA), Instituto de Biología, Pontificia Universidad Católica de Valparaíso, Valparaiso, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Antimicrobial resistance (AMR) surveillance remains predominantly centered on clinical settings, potentially underestimating the community circulation of high-priority carbapenemase determinants. Methods: We integrated culture-based isolation, absolute qPCR, and whole-genome sequencing (WGS) to monitor Results: Total bacterial recovery on antibiotic-free control plates was comparable across seasons, supporting consistent sampling performance. Resistance rates peaked in winter for both ceftazidime (3.7% ± 0.87) and ciprofloxacin (11.1% ± 1.72). Across seasons, 92 morphotypes were recovered, dominated by the genera Conclusions: School wastewater provided a sensitive community sentinel matrix for targeted carbapenemase surveillance, and

Indexed as

AMRblaKPCblaNDMblaVIMcarbapenemase genesEscherichia coli ST1193school wastewaterwastewater-based epidemiology

Identifiers

PMID42112451
PMCPMC13149482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.